We are monitoring the impact of COVID-19 on MEA Genetic Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 25
Share on
Share on

Middle East and Africa Genetic Testing Market Research Report – Segmented By Type, Application and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Size, Share, Growth, Trends, And Forecast (2021 to 2026)

Pulished: April, 2021
ID: 25
Pages: 140

MEA Genetic Testing Market Size (2021 to 2026)

The size of the Genetic Testing Market in the Middle East & Africa was worth USD 3.68 billion in 2021 and is estimated to reach USD 5.07 billion by 2026, growing at a CAGR of 6.64% during the forecast period.

The rise in the prevalence of genetic disorders and cancer has had a favorable impact on the growth of genetic testing in the MEA region. During the forecast period, personalized medicine therapy is expected to boost the market growth.  As the demand for quick, cost-effective, and accurate tests grows, several firms consider giving actionable recommendations alongside the test findings. Customers are more likely to seek out customized services due to this technique, which boosts customer satisfaction. In addition, direct-to-consumer laboratory testing, also known as direct access testing, allows patients to order tests from a lab without going through a healthcare provider.

Genetic testing has been widely used in pharmacogenomics, often known as drug-gene testing. Furthermore, genetic testing methodologies are projected to enhance market growth throughout the forecast period. These test findings can be used to monitor a current health condition, diagnose an undetected medical issue, or provide information on personal health characteristics.

Additionally, factors such as technological advancements in the field of genetic testing, as well as the rising risk of chromosomal abnormalities as maternal age rises, are further estimated to accelerate the growth rate of the market. In addition, the growing incidence of male and female infertility is also forecasted to contribute to the market’s growth.

During the forecast period, however, standardized debates about genetic test-based diagnostics and tight legal requirements for product approvals are projected to hamper the growth of the genetic testing market in the MEA region.

This research report on the MEA genetic testing market has been segmented and sub-segmented into the following categories.

By Application: 

  • Cancer Testing
  • Pharmacogenomics Testing
  • Prenatal Testing
  • Predisposition Testing

By Test: 

  • Carrier Testing
  • Diagnostic Testing
  • Prenatal Testing
  • Neonatal Testing

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the MEA is projected to account for a moderate share in the global genetic testing market in 2020. However, the market in this region is forecasted to register a steady growth rate during the forecast period. Due to increased demand for direct-to-consumer genetic testing and rising consumer interest in personalized medications, MEA has a moderate share of worldwide markets. In addition, the genetic testing market in this region is growing due to increased affordability, rising healthcare spending, and increased awareness of genetic illnesses early detection.

Countries such as UAE and Kuwait are increasing their healthcare capital equipment expenditures, the installed base of various types of products for the genetic testing market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios, all of which affect the genetic testing market.

When present in two copies, individuals with a copy of a gene mutation that causes a hereditary ailment is detected through genetic testing in the research. This type of test is accessible for those who have a family history of genetic disorders and people who are at a higher risk of certain genetic illnesses because of their ethnicity. In addition, if both parents are tested, the test can reveal information regarding the risk of a child developing a genetic condition.

The market for genetic testing in the Middle East and Africa is predicted to rise significantly in the future, owing to an increase in the occurrence of genetic illnesses and cancer and a growing population as more excellent knowledge and adoption of personalized therapies.

KEY MARKET PLAYERS:

Companies that are playing a significant role in the MEA Genetic Testing Market profiled in this report are Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Quest Diagnostics Inc., Transgenomic Inc., and Applied Biosystems Inc. 

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Type        

                                5.1.1 Carrier Testing

                                5.1.2 Diagnostic Testing

                                5.1.3 Prenatal Testing

                                5.1.4 Neonatal Testing

                5.2 By Application           

                                5.2.1 Cancer Testing

                                5.2.2 Prenatal Testing

                                5.2.3 Pharmacogenomics Testing

                                5.2.4 Presdisposition Testing

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 Middle East

                6.3 Africa            

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Roche Molecular Diagnostics Inc.      

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Abbott Laboratories

                8.3 AutoGenomics Inc. 

                8.4 Celera Group             

                8.5 ELITech Group          

                8.6 BioRad Laboratories

                8.7 Quest Diagnostics Inc             

                8.8 Transgenomic Inc.   

                8.9 Applied Biosystems Inc.,       

                8.10 PerkinElmer Inc      

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Genetic Testing Market By Region, From 2021 to 2026 (USD Billion)
  2. Middle East & Africa Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  3. Middle East & Africa Carrier Testing Market By Region, From 2021 to 2026 (USD Billion)
  4. Middle East & Africa Diagnostic Testing Market By Region, From 2021 to 2026 (USD Billion)
  5. Middle East & Africa Prenatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  6. Middle East & Africa Neonatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  7. Middle East & Africa Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)
  8. Middle East & Africa Cancer Testing Market By Region, From 2021 to 2026 (USD Billion)
  9. Middle East & Africa Prenatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  10. Middle East & Africa Pharmacogenomics Testing Market By Region, From 2021 to 2026 (USD Billion)
  11. Middle East & Africa Predisposition Testing Market By Region, From 2021 to 2026 (USD Billion)
  12. Middle East Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  13. Middle East Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)
  14. Africa Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  15. Africa Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample